Which healthcare categories require certification to advertise on Google, and who issues it?

Google requires certification before ads can run in several healthcare-related categories, and the certifier depends on the category and the market — it may be Google itself or an approved third-party verifier such as LegitScript, with NABP accreditation relevant in North America. The categories that require certification include prescription drug services, for which advertisers must apply to serve ads; online pharmacies, which require certification in most markets, commonly through LegitScript, with the National Association of Boards of Pharmacy (NABP) Digital Pharmacy Accreditation relevant in the United States and Canada; telemedicine providers, which require certification in most markets with certifiers varying by location; pharmaceutical manufacturers, who must be certified by Google to serve ads; and, in the United States specifically, health and medical insurance advertisers, who must be certified by Google. Recovery-oriented drug and alcohol addiction services are also restricted and gated rather than freely runnable. The reason certification is layered this way is that healthcare advertising carries direct consumer-safety risk, and Google relies on specialist verifiers — LegitScript and NABP in particular — to assess whether a pharmacy, telehealth provider or related operator is legitimate and properly licensed before it can advertise. For an advertiser, the operational implication is that the first task in any healthcare campaign is to identify exactly which certification path applies, because the requirement varies by both category and country: an online pharmacy in one market may certify through LegitScript, while the same operator in another market faces a different requirement or a prohibition. Certification is also not a one-time formality to be assumed; it must actually be obtained and maintained, and ads will be disapproved until it is in place. Because the requirements and certifiers shift over time and by jurisdiction, advertisers should confirm the current path rather than relying on a previous campaign's setup. For the recent expansion of telehealth and pharmacy verification requirements, see the telehealth and pharmacy verification expansion guide , and align the broader sector approach with the healthcare social-media compliance guide . The organizing principle is that healthcare advertising is gated by category-and-country-specific certification, so identify and complete the correct path — Google, LegitScript, or NABP — before building the campaign.

What healthcare advertising does Google prohibit outright, regardless of certification?

Google prohibits several types of healthcare advertising outright, meaning no certification, targeting change or creative adjustment makes them runnable, and these prohibitions reflect direct consumer-safety and legal concerns rather than gating decisions. The clearest is the rule on prescription drugs without a prescription: offering prescription drugs without a prescription is not allowed, which targets the core harm of enabling consumers to obtain prescription medicines outside a legitimate clinical relationship. Closely related is the categorical ban on prescription opioid painkillers — Google does not allow ads promoting or selling prescription opioid painkillers — a prohibition that reflects the severity of the opioid crisis and is not subject to a certification exception. Google also prohibits speculative and experimental medical treatments, which prevents advertising of unproven interventions marketed as cures or therapies, and it bans unapproved pharmaceuticals and supplements — products that have not received the approval required for the relevant market. Finally, products that have been subject to any government or regulatory action or warning are prohibited, so a product flagged or actioned by a regulator cannot be advertised even if it might otherwise seem to fit a permitted category. The crucial distinction for advertisers is between gated and prohibited. A gated category — prescription drug services, online pharmacies, telemedicine, manufacturers, US insurance — becomes runnable once the correct certification is obtained. A prohibited category cannot be rescued by certification, by adjusting targeting, or by softening the creative; it is simply not permitted, and attempting to run it risks enforcement that can extend beyond a single ad disapproval to account-level consequences for serious or repeated violations. The practical takeaway is that healthcare compliance review must happen at the concept stage: before investing in certification or creative, confirm the product and offer do not fall into a prohibited category, because that determination is binary and final. Advertisers in adjacent spaces — supplements, wellness, devices — should pay particular attention to the unapproved-product and misleading-claim boundaries, since drifting across them converts a permissible campaign into a prohibited one. Audit creative and landing pages against these boundaries with the AI Compliance Audit , and screen language with the Keyword Risk Checker . The organizing principle is that prohibited healthcare categories are a concept-stage gate: certification opens gated categories but cannot open banned ones, so confirm the offer is permitted before anything else.

How do country restrictions affect Google healthcare ads, and why can't a cleared campaign run everywhere?

Country restrictions are a first-order eligibility factor for Google healthcare advertising, and a campaign cleared in one market cannot be assumed eligible in another because the same product, certification and creative can be permitted in one country and prohibited in another. Healthcare advertising eligibility on Google is highly country-dependent by design, reflecting that each jurisdiction regulates medicines, pharmacies and health services differently, and Google's policy maps onto those national rules rather than overriding them. The clearest example is online pharmacies: they are banned entirely in some countries — Poland being a notable case — restricted in others, and permitted with limitations across a broad list of markets, which means an online-pharmacy advertiser must check each target country individually rather than assuming a single global eligibility. Other categories carry their own geographic patterns. Abortion-related ads are restricted in numerous locations, with network-level and query-level restrictions applying in certain regions, so the same ad can be served, limited or blocked depending on the market and even the search context. Clinical-trial recruitment advertising is prohibited in most areas, making it the default-restricted rather than default-permitted. HIV home-test promotion is restricted, with eligibility limited to specific countries under conditions. The consequence for advertisers running multi-country healthcare campaigns is that geography must be treated as a gating question resolved per market: for each target country, confirm that the specific healthcare activity is permitted, that the required local certification or registration is in place, and that no country-specific prohibition applies. A common and costly error is to extend a campaign that was approved in one market — say the United States — into another market without re-checking eligibility, only to encounter disapprovals or, worse, to run non-compliant ads in a market where the activity is restricted. The disciplined approach builds a country-by-country eligibility matrix before launch, pairing each market with its certification requirement and any prohibitions, and revisits it as policies change, since country rules are among the more frequently updated parts of healthcare advertising policy. Track country-level policy movement on the Policy Change Tracker , and align the broader approach with the healthcare social-media compliance guide . The organizing principle is that healthcare eligibility is country-specific, so verify the activity, certification and any prohibition for each target market individually rather than generalizing from one cleared country.

How does Google healthcare certification interact with the platform's broader medical-claim rules?

Google healthcare certification and the platform's broader medical-claim rules operate together: certification establishes that an advertiser is eligible to run a gated healthcare category, while the claim rules govern what the ads in that category may actually say, and an advertiser must satisfy both because being certified does not license misleading or unsupported claims. Certification is about who may advertise and in what category — it confirms, for example, that an online pharmacy is verified through LegitScript or that a US health-insurance advertiser is certified by Google. It does not, however, give the advertiser latitude to make claims that would otherwise violate policy. Google's advertising policies require that ads be truthful and not misleading, and in healthcare this principle is especially consequential because unrealistic or misleading claims about health improvements are prohibited, and unapproved products and speculative or experimental treatments are banned regardless of how they are framed. So a certified telemedicine provider can advertise its service, but it cannot promote that service with claims that overstate medical outcomes, promise unrealistic improvements, or imply efficacy that is not supported. The interaction becomes most important at the boundary categories — supplements, wellness products, and devices — where an advertiser may be eligible to run but can convert a permissible campaign into a non-compliant one through the claims it makes. A supplement that is lawfully sold can still be disapproved if the ad claims it treats or cures a condition, because that crosses from a product-eligibility question into a prohibited-claim question. The practical model for advertisers is to treat certification and claims as two separate checks that both must pass: first, confirm eligibility and obtain the correct certification for the category and market; second, ensure every claim in the creative and on the landing page is substantiated and stays within the bounds of Google's medical-claim rules, avoiding misleading health-improvement language entirely. This two-check discipline prevents the common mistake of assuming that clearing certification means the creative is automatically compliant. To review whether creative claims stay within policy, use the AI Compliance Audit , and screen specific phrasing with the Keyword Risk Checker . The organizing principle is that certification governs eligibility and claim rules govern content, so a certified advertiser must still keep every claim truthful, substantiated and free of prohibited health-improvement language.

What is the practical workflow for launching a compliant Google healthcare campaign in 2026?

The practical workflow for a compliant Google healthcare campaign in 2026 is to classify the category, complete the right certification, verify country eligibility, substantiate claims, and document everything — a sequence that resolves the gating questions before any creative spend, because healthcare disapprovals and enforcement are costly and often avoidable. The first step is classification: determine whether the offer falls into a gated category that becomes runnable with certification — prescription drug services, online pharmacies, telemedicine, pharmaceutical manufacturers, recovery-oriented addiction services, or US health and medical insurance — or into a prohibited category that cannot run at all, such as prescription drugs offered without a prescription, prescription opioid painkillers, speculative or experimental treatments, unapproved pharmaceuticals and supplements, or products under government or regulatory action. If the offer is prohibited, the campaign concept must change; no configuration will make it compliant. The second step, for gated categories, is to complete the correct certification, which may be Google's own certification, LegitScript verification, or NABP Digital Pharmacy Accreditation depending on the category and market — and to obtain it before launch rather than expecting to run while pending. The third step is country eligibility: for each target market, confirm that the specific healthcare activity is permitted, that any local registration is in place, and that no country-specific prohibition applies, building a per-country matrix rather than assuming a campaign cleared in one market travels to others. The fourth step is claim substantiation: ensure that every claim in the creative and on the landing page is supported, and that the ads avoid unrealistic or misleading health-improvement language, because certification does not license unsupported claims. The fifth step is documentation and monitoring: keep records of certifications and country eligibility, review any disapprovals against the specific policy cited rather than guessing, and revisit the setup as policies change, since healthcare rules — especially country-level ones — are updated frequently. Throughout, treat the verticals adjacent to medicine — supplements, wellness, devices — with the same rigor, because they are where permissible campaigns most often drift into prohibited claims. Run a pre-flight review of creative and landing experience with the AI Compliance Audit , screen language with the Keyword Risk Checker , and track changes on the Policy Change Tracker . The organizing principle is classify, certify, verify country eligibility, substantiate claims, and document — gating questions first, creative second.

Google Ads Healthcare Certification 2026: Policy Guide

Quick Answer

Healthcare and medicines is one of the most heavily gated verticals in Google Ads, and advertising in it compliantly in 2026 means treating certification and country eligibility as prerequisites rather than afterthoughts. Google requires certification before ads can run in several healthcare categories. Advertisers must apply to serve ads for prescription drug services; online pharmacies and telemedicine providers require certification in most markets, commonly through LegitScript, with NABP Digital Pharmacy Accreditation relevant in the US and Canada; pharmaceutical manufacturers must be certified by Google; and in the United States, health and medical insurance advertisers must be certified. Several things are prohibited outright: offering prescription drugs without a prescription, prescription opioid painkillers, speculative or experimental medical treatments, unapproved pharmaceuticals and supplements, and products subject to government or regulatory action or warning. Country rules vary sharply — online pharmacies are banned entirely in some countries (such as Poland) and restricted in others, while abortion-related ads, clinical-trial recruitment, and HIV home-test promotion are restricted or limited to specific locations. The compliant posture is to confirm the category requires certification, complete the right certification (Google's own, LegitScript, or NABP as applicable), verify the target country permits the activity, and keep claims within Google's healthcare rules. Screen creative with the Keyword Risk Checker, audit the full experience with the AI Compliance Audit, and track changes on the Policy Change Tracker.

Google Ads Healthcare and Medicines Compliance in 2026: Certification, LegitScript and Prohibited Categories

Why Healthcare Is Google's Most Gated Vertical

Healthcare and medicines advertising on Google is governed by a dense layer of certification, prohibition and country-specific rules that few other verticals match. The reason is straightforward: health advertising can cause direct consumer harm if it promotes unapproved products, enables prescription drugs to be obtained without a prescription, or makes unsupported medical claims, so Google gates the category heavily and applies third-party verification on top of its own policies.

For an advertiser, the practical consequence is that healthcare campaigns cannot be launched on the assumption that a compliant product equals a runnable ad. Certification, country eligibility and claim substantiation are prerequisites, and missing any of them results in disapproval or, for serious or repeated violations, account-level enforcement.

"In healthcare, Google treats certification and country eligibility as gates, not formalities. The compliant advertiser confirms both before building creative, not after a disapproval.
— AuditSocials analysis of Google's healthcare and medicines policy"

This guide covers which categories require certification, what is prohibited outright, how country restrictions work, and the workflow to advertise healthcare compliantly. For the sector view, see the healthcare social-media compliance guide; for Google Ads policy broadly, see the Google Ads policy guide.

Which Categories Require Certification

Google requires certification before ads can run in several healthcare-related categories. Certification may be issued by Google itself, or by a third-party verifier such as LegitScript, depending on the category and market.

Certification Map

Category	Certification requirement
Prescription drug services	Advertisers must apply to serve ads for prescription drug services
Online pharmacies	Certification required in most markets; commonly LegitScript, with NABP Digital Pharmacy Accreditation relevant in the US and Canada
Telemedicine	Certification required in most markets, with certifiers varying by location
Pharmaceutical manufacturers	Must be certified by Google to serve ads
Addiction services	Promotion of recovery-oriented drug and alcohol addiction services is restricted and gated
Health and medical insurance (US)	In the United States, advertisers must be certified by Google

Because certifiers and requirements vary by category and country, the first step in any healthcare campaign is to identify exactly which certification path applies. For the recent expansion of telehealth and pharmacy verification, see the telehealth and pharmacy verification expansion guide. Screen creative against high-risk health language with the Keyword Risk Checker.

What Google Prohibits Outright

Some healthcare advertising is not gated but banned — no certification makes it runnable. These prohibitions reflect direct consumer-safety and legal concerns.

Banned in Google Ads

Prescription drugs without a prescription: Offering prescription drugs without a prescription is not allowed.
Prescription opioid painkillers: Google does not allow ads promoting or selling prescription opioid painkillers.
Speculative or experimental treatments: Speculative and experimental medical treatments are prohibited.
Unapproved pharmaceuticals and supplements: Products not approved for the relevant market are not allowed.
Products under regulatory action or warning: Products subject to any government or regulatory action or warning are prohibited.

The distinction matters: a gated category becomes runnable once certified, but a prohibited category cannot be rescued by certification or by adjusting targeting. The opioid and unapproved-product bans in particular are categorical, and attempting to run them risks enforcement beyond a single disapproval. Audit creative and landing pages with the AI Compliance Audit before submission.

Country-by-Country Restrictions

Healthcare advertising eligibility on Google is highly country-dependent. The same product and certification can be permitted in one market and prohibited in another, so geography is a first-order eligibility question rather than a detail.

How Geography Shapes Eligibility

Pharmacy bans: Online pharmacies are banned entirely in some countries, such as Poland, and restricted in others, while permitted with limitations across a wide list of markets.
Abortion-related ads: Restricted in numerous locations, with network and query-level restrictions applying in certain regions.
Clinical-trial recruitment: Prohibited in most areas.
HIV home tests: Restricted, with promotion limited to specific countries under conditions.

The practical rule is to verify, for each target country, that the specific healthcare activity is permitted and that the required local certification or registration is in place — a campaign cleared in one market should never be assumed eligible in another. Track country-level policy movement on the Policy Change Tracker.

A Compliant Healthcare Advertising Workflow

The defensible workflow treats certification, country eligibility and claim substantiation as sequential gates resolved before creative is built.

Step by Step

Classify the category: Is it gated (prescription services, online pharmacy, telemedicine, manufacturer, addiction services, US insurance) or prohibited (prescription without Rx, opioids, speculative treatments, unapproved products)?
Complete the right certification: Google certification, LegitScript, or NABP accreditation as applicable to the category and market.
Verify country eligibility: Confirm the activity is permitted in each target country and that local registration is in place.
Substantiate claims: Keep health claims supported and avoid unrealistic or misleading health-improvement language.
Monitor and document: Keep certification records and review disapprovals against the specific policy cited.

Run a pre-flight review of creative and landing experience with the AI Compliance Audit, and screen copy with the Keyword Risk Checker.

Google Healthcare Ads Checklist

[ ] Category classified as gated (certifiable) or prohibited
[ ] Required certification obtained — Google, LegitScript, or NABP as applicable
[ ] Prescription drug services application approved where required
[ ] No prescription drugs offered without a prescription
[ ] No opioid painkillers, speculative/experimental treatments, or unapproved products
[ ] No products under government or regulatory action or warning
[ ] Target country confirmed to permit the specific healthcare activity
[ ] Local registration or accreditation in place per market
[ ] Health claims substantiated and free of misleading improvement language
[ ] Certification records kept and disapprovals reviewed against the cited policy

Don't miss the next policy change.

Create a free account — track every policy change across 8 platforms, get instant alerts, and access every free compliance tool. Or try our Keyword Risk Checker first.

Create Free Account

Report Keywords — Run AI Compliance Audit

#Google Ads#Healthcare#Ad Compliance#Certification#LegitScript#Pharmacy#Telehealth#Prescription Drugs#Advertisers#Brand Safety#Compliance Guide 2026#Disclosure Rules

Share This Report

Tweet Share

Privacy Sandbox Is Gone: What the 2026 Retargeting and Measurement Reality Means for Advertiser Compliance

Google retired Topics, Protected Audience and Attribution Reporting, while third-party cookies stayed but grew unreliable — the 2026 retargeting and measurement reality.

Performance Max Brand Safety in 2026: Placement Transparency, Exclusions and Account-Level Controls

Performance Max automates placement across Google's network, but brand safety stays the advertiser's job. Account-level controls and new placement reporting are how you keep ads off unsafe inventory.

Google Performance Max Auto-Generated Asset Disclosure May 2026: AI Creative Labelling, Asset Approval Cap & Advertiser Workflow

Google Performance Max's May 2026 update tightens auto-generated asset disclosure — AI-created variants now carry visible labels, asset approval caps narrow, and advertiser-side review burden lands.

Google Ads Healthcare and Medicines Compliance in 2026: Certification, LegitScript and Prohibited Categories